Education
About Us
Working with TipRanks
Follow Us
InnoCan Pharma (TSE:INNO)
:INNO
INNO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.15 - C$0.27
Previous CloseN/A
Volume118.77K
Average Volume (3M)85.80K
Market Cap
$68.72M
Enterprise ValueC$56.30M
Total Cash (Recent Filing)$6.37M
Total Debt (Recent Filing)$1.30M
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding292,420,170
10 Day Avg. Volume132,860
30 Day Avg. Volume85,797
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue1.85
Enterprise Value/Gross Profit2.06
Enterprise Value/Ebitda42.88
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
InnoCan Pharma News
INNO FAQ
What was InnoCan Pharma’s price range in the past 12 months?
InnoCan Pharma lowest stock price was C$0.15 and its highest was C$0.27 in the past 12 months.
What is InnoCan Pharma’s market cap?
InnoCan Pharma’s market cap is $68.72M.
When is InnoCan Pharma’s upcoming earnings report date?
InnoCan Pharma’s upcoming earnings report date is Sep 01, 2025 which is in 24 days.
How were InnoCan Pharma’s earnings last quarter?
Currently, no data Available
Is InnoCan Pharma overvalued?
According to Wall Street analysts InnoCan Pharma’s price is currently Overvalued.
Does InnoCan Pharma pay dividends?
InnoCan Pharma does not currently pay dividends.
What is InnoCan Pharma’s EPS estimate?
InnoCan Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InnoCan Pharma have?
InnoCan Pharma has 292,420,170 shares outstanding.
What happened to InnoCan Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InnoCan Pharma?
Currently, no hedge funds are holding shares in TSE:INNO
Company Description
InnoCan Pharma
InnoCan Pharma (INNO) is a pharmaceutical company engaged in the research, development, and commercialization of innovative therapeutic products. The company operates primarily in the biotechnology and pharmaceutical sectors, focusing on developing novel treatments utilizing its proprietary technology platforms. InnoCan Pharma is known for leveraging cannabinoid science and liposome technology to create therapies aimed at improving health and wellness.
InnoCan Pharma (INNO) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Mountain Valley MD
―
Medicure
―
Medexus Pharmaceuticals Inc
―
Revive Therapeutics
―
BioNxt Solutions
―
Ownership Overview
5.66% Insiders
―
Mutual Funds
― Other Institutional Investors
94.34% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---